Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Accelerate Diagnostics, IncAXDX · Entity 78156 | Director · Chief Executive Officer | April 04, 2025 | April 07, 2025 |
| BRUKER CORPBRKR · Entity 3609 | Director | February 15, 2026 | February 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Accelerate Diagnostics, Inc
Report date April 04, 2025 · Filed April 07, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 191,374 |
Ending reported balance
After 2025-04-04 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-04-04 · Exercise / conversion · Acquired 53,283 · Balance 216,717 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. Row 2 · 2025-04-04 · Sale · Disposed 25,343 · Balance 191,374 F2: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person. |
| Employee Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-04-04 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-04-04 · Exercise / conversion · Disposed 53,283 · Balance 0 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. F3: On April 4, 2022, the reporting person was granted a total of 88,806 RSUs, of which 40% vest on April 4, 2024 and the remaining 60% vest on April 4, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting.
F2: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
F3: On April 4, 2022, the reporting person was granted a total of 88,806 RSUs, of which 40% vest on April 4, 2024 and the remaining 60% vest on April 4, 2025.
BRUKER CORP
Report date February 15, 2026 · Filed February 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,520 |
Reported balance
After 2026-02-15 transaction · row 1
1 source rowRow 1 · 2026-02-15 · Grant · Acquired 4,520 · Balance 4,520 F1: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2026 Filed Feb 18, 2026 21:15 UTC | BRUKER CORP BRKR · Entity 3609 | GrantCommon Stock | 4,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001784805-26-000007 · form4-02182026_040219.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,520 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| April 04, 2025 Filed Apr 7, 2025 19:34 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 53,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-032762 · tm2511653-2_4seq1.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 53,283 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. F3 · derivative.exercise_date: On April 4, 2022, the reporting person was granted a total of 88,806 RSUs, of which 40% vest on April 4, 2024 and the remaining 60% vest on April 4, 2025. F3 · derivative.expiration_date: On April 4, 2022, the reporting person was granted a total of 88,806 RSUs, of which 40% vest on April 4, 2024 and the remaining 60% vest on April 4, 2025. Read SEC document |
| April 04, 2025 Filed Apr 7, 2025 19:34 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 25,343 | $0.65 | $16,472.95 |
DisclosureSEC source: 0001104659-25-032762 · tm2511653-2_4seq1.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,374 F2 · shares: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person. Read SEC document |
| April 04, 2025 Filed Apr 7, 2025 19:34 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 53,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-032762 · tm2511653-2_4seq1.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. Read SEC document |
| February 03, 2025 Filed Feb 4, 2025 16:10 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 485 | $1.35 | $654.75 |
DisclosureSEC source: 0001104659-25-009104 · tm255423-1_4seq1.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,434 F2 · shares: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 16:10 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-009104 · tm255423-1_4seq1.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. F3 · derivative.exercise_date: On February 1, 2020, the reporting person was granted a total of 5,000 RSUs, which vest in equal annual amounts on each anniversary of the grant date over five years, beginning on February 1, 2021 and ending on February 1, 2025. F3 · derivative.expiration_date: On February 1, 2020, the reporting person was granted a total of 5,000 RSUs, which vest in equal annual amounts on each anniversary of the grant date over five years, beginning on February 1, 2021 and ending on February 1, 2025. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 16:10 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-009104 · tm255423-1_4seq1.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,919 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. Read SEC document |
| May 29, 2024 Filed May 30, 2024 16:25 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | GrantEmployee Restricted Stock Units · Derivative | 360,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-066666 · tm2415918-3_4seq1.xml · derivative · entry 1 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 360,000 Underlying: Common Stock · 360,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. F2 · derivative.exercise_date: On May 29, 2024, the reporting person was granted a total of 360,000 RSUs, of which 40% vest on May 29, 2026 and the remaining 60% vest on May 29, 2027. F2 · derivative.expiration_date: On May 29, 2024, the reporting person was granted a total of 360,000 RSUs, of which 40% vest on May 29, 2026 and the remaining 60% vest on May 29, 2027. Read SEC document |
| April 17, 2024 Filed Apr 18, 2024 16:10 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 59,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-048843 · tm2412157-1_4seq1.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 59,928 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On March 5, 2024, the reporting person was granted a total of 119,856 restricted stock units ("RSUs"), of which 50% vest on April 12, 2024 and the remaining 50% vest on April 17, 2024. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting. F1 · derivative.exercise_date: On March 5, 2024, the reporting person was granted a total of 119,856 restricted stock units ("RSUs"), of which 50% vest on April 12, 2024 and the remaining 50% vest on April 17, 2024. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting. F1 · derivative.expiration_date: On March 5, 2024, the reporting person was granted a total of 119,856 restricted stock units ("RSUs"), of which 50% vest on April 12, 2024 and the remaining 50% vest on April 17, 2024. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting. Read SEC document |
| April 17, 2024 Filed Apr 18, 2024 16:10 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 26,735 | $0.78 | $20,853.30 |
DisclosureSEC source: 0001104659-24-048843 · tm2412157-1_4seq1.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 162,919 F2 · shares: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person. Read SEC document |
| April 17, 2024 Filed Apr 18, 2024 16:10 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 59,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-048843 · tm2412157-1_4seq1.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 189,654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On March 5, 2024, the reporting person was granted a total of 119,856 restricted stock units ("RSUs"), of which 50% vest on April 12, 2024 and the remaining 50% vest on April 17, 2024. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting. F1 · price: On March 5, 2024, the reporting person was granted a total of 119,856 restricted stock units ("RSUs"), of which 50% vest on April 12, 2024 and the remaining 50% vest on April 17, 2024. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting. Read SEC document |
| April 12, 2024 Filed Apr 16, 2024 16:10 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 59,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-047780 · tm2411941-1_4seq1.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,928 Underlying: Common Stock · 59,928 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On March 5, 2024, the reporting person was granted a total of 119,856 restricted stock units ("RSUs"), of which 50% vest on April 12, 2024 and the remaining 50% vest on April 17, 2024. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting. F1 · derivative.exercise_date: On March 5, 2024, the reporting person was granted a total of 119,856 restricted stock units ("RSUs"), of which 50% vest on April 12, 2024 and the remaining 50% vest on April 17, 2024. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting. F1 · derivative.expiration_date: On March 5, 2024, the reporting person was granted a total of 119,856 restricted stock units ("RSUs"), of which 50% vest on April 12, 2024 and the remaining 50% vest on April 17, 2024. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting. Read SEC document |
| April 12, 2024 Filed Apr 16, 2024 16:10 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 26,545 | $0.86 | $22,828.70 |
DisclosureSEC source: 0001104659-24-047780 · tm2411941-1_4seq1.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 129,726 F2 · shares: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person. Read SEC document |
| April 12, 2024 Filed Apr 16, 2024 16:10 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 59,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-047780 · tm2411941-1_4seq1.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 156,271 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On March 5, 2024, the reporting person was granted a total of 119,856 restricted stock units ("RSUs"), of which 50% vest on April 12, 2024 and the remaining 50% vest on April 17, 2024. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting. F1 · price: On March 5, 2024, the reporting person was granted a total of 119,856 restricted stock units ("RSUs"), of which 50% vest on April 12, 2024 and the remaining 50% vest on April 17, 2024. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting. Read SEC document |
| April 04, 2024 Filed Apr 5, 2024 16:26 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 35,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-044294 · tm2411185-1_4seq1.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,283 Underlying: Common Stock · 35,523 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On April 4, 2022, the reporting person was granted a total of 88,806 restricted stock units ("RSUs"), of which 40% vest on April 4, 2024 and the remaining 60% vest on April 4, 2025. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting. F1 · derivative.exercise_date: On April 4, 2022, the reporting person was granted a total of 88,806 restricted stock units ("RSUs"), of which 40% vest on April 4, 2024 and the remaining 60% vest on April 4, 2025. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting. F1 · derivative.expiration_date: On April 4, 2022, the reporting person was granted a total of 88,806 restricted stock units ("RSUs"), of which 40% vest on April 4, 2024 and the remaining 60% vest on April 4, 2025. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting. Read SEC document |
| April 04, 2024 Filed Apr 5, 2024 16:26 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 15,887 | $0.88 | $13,980.56 |
DisclosureSEC source: 0001104659-24-044294 · tm2411185-1_4seq1.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,343 F2 · shares: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person. Read SEC document |
| April 04, 2024 Filed Apr 5, 2024 16:26 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 35,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-044294 · tm2411185-1_4seq1.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,230 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On April 4, 2022, the reporting person was granted a total of 88,806 restricted stock units ("RSUs"), of which 40% vest on April 4, 2024 and the remaining 60% vest on April 4, 2025. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting. F1 · price: On April 4, 2022, the reporting person was granted a total of 88,806 restricted stock units ("RSUs"), of which 40% vest on April 4, 2024 and the remaining 60% vest on April 4, 2025. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting. Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 19:30 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | GrantEmployee Restricted Stock Units · Derivative | 119,856 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-031598 · tm248096-1_4seq1.xml · derivative · entry 1 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,856 Underlying: Common Stock · 119,856 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. F2 · derivative.exercise_date: On March 5, 2024, the reporting person was granted a total of 119,856 RSUs, of which 50% vest on April 12, 2024 and the remaining 50% vest on April 17, 2024. F2 · derivative.expiration_date: On March 5, 2024, the reporting person was granted a total of 119,856 RSUs, of which 50% vest on April 12, 2024 and the remaining 50% vest on April 17, 2024. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 16:48 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-010102 · tm245035-1_4seq1.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU upon vesting. On February 1, 2020, the reporting person was granted a total of 5,000 RSUs, which vest in equal annual amounts on each anniversary of the grant date over five years, beginning on February 1, 2021 and ending on February 1, 2025. F1 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU upon vesting. On February 1, 2020, the reporting person was granted a total of 5,000 RSUs, which vest in equal annual amounts on each anniversary of the grant date over five years, beginning on February 1, 2021 and ending on February 1, 2025. F1 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU upon vesting. On February 1, 2020, the reporting person was granted a total of 5,000 RSUs, which vest in equal annual amounts on each anniversary of the grant date over five years, beginning on February 1, 2021 and ending on February 1, 2025. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 16:48 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 494 | $1.30 | $642.20 |
DisclosureSEC source: 0001104659-24-010102 · tm245035-1_4seq1.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,707 F2 · shares: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 16:48 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-010102 · tm245035-1_4seq1.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU upon vesting. On February 1, 2020, the reporting person was granted a total of 5,000 RSUs, which vest in equal annual amounts on each anniversary of the grant date over five years, beginning on February 1, 2021 and ending on February 1, 2025. F1 · price: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU upon vesting. On February 1, 2020, the reporting person was granted a total of 5,000 RSUs, which vest in equal annual amounts on each anniversary of the grant date over five years, beginning on February 1, 2021 and ending on February 1, 2025. Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 16:11 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | GrantCommon Stock Warrants (right to buy) · Derivative | 16,666 | Not disclosed Strike: $1.65 | Not disclosed |
DisclosureSEC source: 0001104659-24-006676 · tm244005-3_4seq1.xml · derivative · entry 2 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,666 Underlying: Common Stock · 16,666 shares Expires 2029-01-23 F1 · price: The reported securities are included within 16,666 units of the issuer (the "Units") purchased by the reporting person for $1.50 per Unit from the issuer in an offering exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended. Each Unit consists of one share of the issuer's common stock and one warrant to purchase one share of the issuer's common stock. Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 16:11 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | GrantCommon Stock | 16,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-006676 · tm244005-3_4seq1.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,201 F1 · price: The reported securities are included within 16,666 units of the issuer (the "Units") purchased by the reporting person for $1.50 per Unit from the issuer in an offering exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended. Each Unit consists of one share of the issuer's common stock and one warrant to purchase one share of the issuer's common stock. Read SEC document |
| December 13, 2023 Filed Dec 14, 2023 17:15 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 1,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-126068 · tm2332887-2_4seq1.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,721 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. Read SEC document |
| December 13, 2023 Filed Dec 14, 2023 17:15 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 739 | $4.39 | $3,244.21 |
DisclosureSEC source: 0001104659-23-126068 · tm2332887-2_4seq1.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,535 F2 · shares: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person. Read SEC document |
| December 13, 2023 Filed Dec 14, 2023 17:15 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 1,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-126068 · tm2332887-2_4seq1.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,274 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · price: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. Read SEC document |
| November 13, 2023 Filed Nov 14, 2023 17:05 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 1,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-118226 · tm2330666-2_4seq1.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,721 Underlying: Common Stock · 1,722 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. Read SEC document |
| November 13, 2023 Filed Nov 14, 2023 17:05 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 745 | $5.58 | $4,157.10 |
DisclosureSEC source: 0001104659-23-118226 · tm2330666-2_4seq1.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,553 F2 · shares: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person. Read SEC document |
| November 13, 2023 Filed Nov 14, 2023 17:05 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 1,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-118226 · tm2330666-2_4seq1.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · price: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. Read SEC document |
| October 13, 2023 Filed Oct 16, 2023 17:16 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 1,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-034441 · wk-form4_1697491002.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,443 Underlying: Common Stock · 1,721 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. Read SEC document |
| October 13, 2023 Filed Oct 16, 2023 17:16 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 734 | $5.83 | $4,279.22 |
DisclosureSEC source: 0001628280-23-034441 · wk-form4_1697491002.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,576 F2 · shares: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person. Read SEC document |
| October 13, 2023 Filed Oct 16, 2023 17:16 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 1,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-034441 · wk-form4_1697491002.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · price: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. Read SEC document |
| September 13, 2023 Filed Sep 14, 2023 16:13 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 1,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-100790 · tm2326124-2_4seq1.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,164 Underlying: Common Stock · 1,722 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. Read SEC document |
| September 13, 2023 Filed Sep 14, 2023 16:13 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 733 | $6.53 | $4,786.49 |
DisclosureSEC source: 0001104659-23-100790 · tm2326124-2_4seq1.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,589 F2 · shares: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person. Read SEC document |
| September 13, 2023 Filed Sep 14, 2023 16:13 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 1,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-100790 · tm2326124-2_4seq1.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,322 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · price: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. Read SEC document |
| August 14, 2023 Filed Aug 15, 2023 19:22 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 751 | $6.80 | $5,106.80 |
DisclosureSEC source: 0001628280-23-029597 · wk-form4_1692141763.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,600 F2 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| August 13, 2023 Filed Aug 15, 2023 19:22 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 1,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-029597 · wk-form4_1692141763.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,886 Underlying: Common Stock · 1,721 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. Read SEC document |
| August 13, 2023 Filed Aug 15, 2023 19:22 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 1,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-029597 · wk-form4_1692141763.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,351 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:11 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 1,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-025006 · wk-form4_1689628289.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,607 Underlying: Common Stock · 1,722 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:11 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 729 | $6.90 | $5,030.10 |
DisclosureSEC source: 0001628280-23-025006 · wk-form4_1689628289.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,629 F2 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:11 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 1,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-025006 · wk-form4_1689628289.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,358 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. Read SEC document |
| June 26, 2023 Filed Jun 26, 2023 18:48 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | GrantEmployee Restricted Stock Units · Derivative | 3,131,579 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-023503 · wk-form4_1687819678.xml · derivative · entry 4 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,131,579 Underlying: Common Stock · 3,131,579 shares Expires not disclosed F3 · derivative.exercise_price: The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Common Stock for each RSU. The reporting person received 3,131,579 RSUs on June 26, 2023. 626,316 RSUs vest on June 26, 2025, 626,316 RSUs vest on July 10, 2025, 939,474 RSUs vest on June 26, 2026, and 939,473 RSUs vest on July 10, 2027. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F3 · derivative.exercise_date: The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Common Stock for each RSU. The reporting person received 3,131,579 RSUs on June 26, 2023. 626,316 RSUs vest on June 26, 2025, 626,316 RSUs vest on July 10, 2025, 939,474 RSUs vest on June 26, 2026, and 939,473 RSUs vest on July 10, 2027. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F4 · derivative.expiration_date: Not Applicable. Read SEC document |
| June 26, 2023 Filed Jul 10, 2023 20:04 UTC Amendment | Accelerate Diagnostics, Inc AXDX · Entity 78156 | GrantEmployee Restricted Stock Units · Derivative | 3,131,579 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-024660 · wk-form4a_1689033848.xml · derivative · entry 1 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,131,579 Underlying: Common Stock · 3,131,579 shares Expires not disclosed F1 · derivative.exercise_price: On June 26, 2023, the reporting person filed a Form 4, which inadvertently reported an incorrect vesting date for the 3,131,579 restricted stock units ("RSUs") granted to the reporting person on June 26, 2023. The RSUs represent a contingent right to receive one share of common stock for each RSU. 626,316 RSUs vest on June 26, 2025, 626,316 RSUs vest on July 10, 2025, 939,474 RSUs vest on June 26, 2026, and 939,473 RSUs vest on July 10, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. F1 · derivative.exercise_date: On June 26, 2023, the reporting person filed a Form 4, which inadvertently reported an incorrect vesting date for the 3,131,579 restricted stock units ("RSUs") granted to the reporting person on June 26, 2023. The RSUs represent a contingent right to receive one share of common stock for each RSU. 626,316 RSUs vest on June 26, 2025, 626,316 RSUs vest on July 10, 2025, 939,474 RSUs vest on June 26, 2026, and 939,473 RSUs vest on July 10, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. F2 · derivative.expiration_date: Not applicable. Read SEC document |
| June 22, 2023 Filed Jun 26, 2023 18:48 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 62,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-023503 · wk-form4_1687819678.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,160 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On June 22, 2020, the reporting person was granted a total of 186,480 RSUs, which vested in equal amounts on each anniversary date, over three years, beginning June 22, 2021 and ending on June 22, 2023. F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On June 22, 2020, the reporting person was granted a total of 186,480 RSUs, which vested in equal amounts on each anniversary date, over three years, beginning June 22, 2021 and ending on June 22, 2023. F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On June 22, 2020, the reporting person was granted a total of 186,480 RSUs, which vested in equal amounts on each anniversary date, over three years, beginning June 22, 2021 and ending on June 22, 2023. Read SEC document |
| June 22, 2023 Filed Jun 26, 2023 18:48 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 27,262 | $0.71 | $19,356.02 |
DisclosureSEC source: 0001628280-23-023503 · wk-form4_1687819678.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 536,362 F2 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| June 22, 2023 Filed Jun 26, 2023 18:48 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 62,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-023503 · wk-form4_1687819678.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 563,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On June 22, 2020, the reporting person was granted a total of 186,480 RSUs, which vested in equal amounts on each anniversary date, over three years, beginning June 22, 2021 and ending on June 22, 2023. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On June 22, 2020, the reporting person was granted a total of 186,480 RSUs, which vested in equal amounts on each anniversary date, over three years, beginning June 22, 2021 and ending on June 22, 2023. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 13:18 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 17,216 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-022177 · wk-form4_1686849520.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,299 Underlying: Common Stock · 17,216 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 13:18 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 8,390 | $0.90 | $7,551.00 |
DisclosureSEC source: 0001628280-23-022177 · wk-form4_1686849520.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 501,464 F2 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 13:18 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 17,216 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-022177 · wk-form4_1686849520.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 509,854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. Read SEC document |
| May 15, 2023 Filed May 16, 2023 17:38 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 17,217 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-018497 · wk-form4_1684273120.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,515 Underlying: Common Stock · 17,217 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.